Malawi researchers to tap into GSK’s £4m for cancer, diabetes

Map Of MalawiHealth researchers from Malawi are in line to tap from a £4m first round of funding that one of the world’s leading pharmaceuticals firms GSK has made available for eight African countries to research into non-communicable diseases (NCDs) such as cancer, diabetes and chronic kidney disease.

GSK said on Friday it has launched the first call for proposals for its Africa NCD Open Lab to support much-needed scientific research into outbreak of NCDs on the continent.


Read More